Join Dr. Paul Kolodzik on this episode of The Second Opinion as he explores the future of GLP-1 medications. Delve into the intriguing and concerning rise of Black Market GLP-1s and the potential implications for patients and healthcare systems. Additionally, Dr. Kolodzik discusses the development of GLP-1 in pill form—what it means for accessibility, efficacy, and patient convenience. Stay informed about these cutting-edge developments in GLP-1 therapies and their impact on weight management...
All content for The Second Opinion Podcast with Dr. Paul Kolodzik is the property of DR. Paul Kolodzik and is served directly from their servers
with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
Join Dr. Paul Kolodzik on this episode of The Second Opinion as he explores the future of GLP-1 medications. Delve into the intriguing and concerning rise of Black Market GLP-1s and the potential implications for patients and healthcare systems. Additionally, Dr. Kolodzik discusses the development of GLP-1 in pill form—what it means for accessibility, efficacy, and patient convenience. Stay informed about these cutting-edge developments in GLP-1 therapies and their impact on weight management...
E94: Drink Less with Medication - Second Opinion Podcast with Dr. Paul Kolodzik
The Second Opinion Podcast with Dr. Paul Kolodzik
24 minutes
1 month ago
E94: Drink Less with Medication - Second Opinion Podcast with Dr. Paul Kolodzik
Your latest episode of "Second Opinion with Dr. Paul Kolodzik," E94: Drink Less with Medication using naltrexone and GLP-1, focuses on innovative approaches to reducing alcohol consumption. Dr. Kolodzik reviews how medications like naltrexone and GLP-1 receptor agonists are being used to help individuals manage and decrease their alcohol intake. Tune in to learn about the science behind these treatments, their effectiveness, and how they can improve health outcomes. Whether you're inter...
The Second Opinion Podcast with Dr. Paul Kolodzik
Join Dr. Paul Kolodzik on this episode of The Second Opinion as he explores the future of GLP-1 medications. Delve into the intriguing and concerning rise of Black Market GLP-1s and the potential implications for patients and healthcare systems. Additionally, Dr. Kolodzik discusses the development of GLP-1 in pill form—what it means for accessibility, efficacy, and patient convenience. Stay informed about these cutting-edge developments in GLP-1 therapies and their impact on weight management...
